Johnson & Johnson Website

Johnson & Johnson

NYSE-JNJ

Basic

  • Market Cap

    $384.2B

  • EV

    $391.62B

  • Shares Out

    2,406.68M

  • Revenue

    $86.58B

  • Employees

    131,900

Margins

  • Gross

    69.29%

  • EBITDA

    35.98%

  • Operating

    27.98%

  • Pre-Tax

    22.53%

  • Net

    43.91%

  • FCF

    20.88%

Returns (5Yr Avg)

  • ROA

    11.47%

  • ROTA

    96.6%

  • ROE

    30.06%

  • ROCE

    17.57%

  • ROIC

    16.18%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $170.67

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $26.22B

  • Net Debt

    $7,414M

  • Debt/Equity

    0.48

  • EBIT/Interest

    31.38

Growth (CAGR)

  • Rev 3Yr

    -0.99%

  • Rev 5Yr

    1.26%

  • Rev 10Yr

    1.67%

  • Dil EPS 3Yr

    32.44%

  • Dil EPS 5Yr

    20.73%

  • Dil EPS 10Yr

    11.07%

  • Rev Fwd 2Yr

    3.42%

  • EBITDA Fwd 2Yr

    2.81%

  • EPS Fwd 2Yr

    4.01%

  • EPS LT Growth Est

    3.95%

Dividends

  • Yield

    —

  • Payout

    71.42%

  • DPS

    $4.81

  • DPS Growth 3Yr

    5.55%

  • DPS Growth 5Yr

    5.67%

  • DPS Growth 10Yr

    6.02%

  • DPS Growth Fwd 2Yr

    4.52%

Select a metric from the list below to chart it

Dec '14

Jan '16

Jan '17

Dec '17

Dec '18

Dec '19

Jan '21

Jan '22

Jan '23

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Jan '16
Jan '17
Dec '17
Dec '18
Dec '19
Jan '21
Jan '22
Jan '23
Dec '23
LTM

Total Revenues

82,059

82,584

78,740

79,990

85,159

86,576

Total Revenues % Chg.

0.6%

0.6%

-4.7%

1.6%

6.5%

-11%

Cost of Goods Sold, Total

27,556

28,427

23,402

24,596

26,244

26,585

Gross Profit

54,503

54,157

55,338

55,394

58,915

59,991

Selling General & Admin Expenses, Total

21,885

21,731

19,506

19,078

20,166

20,808

R&D Expenses

11,355

12,159

14,277

14,135

15,085

14,955

Other Operating Expenses, Total

33,240

33,890

33,783

33,213

35,251

35,763

Operating Income

21,263

20,267

21,555

22,181

23,664

24,228

Interest Expense, Total

-318

-201

-183

-276

-772

-772

Interest And Investment Income

357

111

53

490

1,261

1,500

Net Interest Expenses

39

-90

-130

214

489

728

Currency Exchange Gains (Loss)

-267

-209

-216

-286

-366

-366

Other Non Operating Income (Expenses)

-3,909

-2,922

-550

1,744

1,664

1,669

EBT, Excl. Unusual Items

17,126

17,046

20,659

23,853

25,451

26,259

Restructuring Charges

—

-266

-247

-209

-275

-798

-683

Merger & Related Restructuring Charges

—

—

—

—

—

—

-300

-200

-720

Gain (Loss) On Sale Of Investments

—

—

—

—

—

300

1

—

-700

-600

-940

Gain (Loss) On Sale Of Assets

2,154

111

617

380

117

117

Asset Writedown

—

-1,096

-233

-989

-1,216

-1,295

-1,295

In Process R&D Expenses

-890

-181

-900

-783

-313

-458

Legal Settlements

—

—

—

—

—

—

-900

-6,900

-2,941

Other Unusual Items

—

—

—

—

—

—

—

—

-700

-400

166

EBT, Incl. Unusual Items

17,328

16,497

19,178

19,359

15,062

19,505

Income Tax Expense

2,209

1,783

1,377

2,989

1,736

3,123

Earnings From Continuing Operations

15,119

14,714

17,801

16,370

13,326

16,382

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

3,077

1,571

21,827

21,636

Net Income

15,119

14,714

20,878

17,941

35,153

38,018

Net Income to Common Incl Extra Items

15,119

14,714

20,878

17,941

35,153

38,018

Net Income to Common Excl. Extra Items

15,119

14,714

17,801

16,370

13,326

16,382

Total Shares Outstanding

2,632.5

2,632.5

2,629

2,613.6

2,407.1

2,422

Weighted Avg. Shares Outstanding

2,645.1

2,632.8

2,632.1

2,625.2

2,533.5

2,432.4

Weighted Avg. Shares Outstanding Dil

2,684.3

2,670.7

2,674

2,663.9

2,560.4

2,459.3

EPS

5.7

5.6

7.9

6.8

13.9

15.6

EPS Diluted

5.6

5.5

7.8

6.7

13.7

15.5

EBITDA

28,272

27,498

28,206

28,510

30,767

31,147

Effective Tax Rate

12.7%

10.8%

7.2%

15.4%

11.5%

16%